Empiric Antibiotic Choice for Hospitalized Patients with Community-Acquired Pneumonia: β-lactam/β-lactamase inhibitor or Fluoroquinolone Alone?
Fatma Tokgöz Akyıl, Mustafa Akyıl, Aylin Güngör, Neslihan Köse, Kübra Akyüz, Sümeyye Bekir, Hatice Türker, Tülin Sevim
(Thorac Res Pract 2019; 20: 124-124) DOI: 10.5152/TurkThoracJ.2019.124